基于纳米技术的西斯普拉丁输送用于ORL癌症的进展:全面审查
Anda Ioana Morgovan1, Eugen Radu Boia1, Alexandru Catalin Motofelea2
1Department of Ear, Nose and Throat, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy Timisoara, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania.
International journal of molecular sciences
|June 13, 2025
概括
纳米技术增强了对头部和部癌症的西斯白输送,改善了向性和减少毒性. 需要进一步的研究来克服临床使用的挑战.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
背景情况:
- 耳鼻喉 (ORL) 癌症带来了重大的瘤挑战.
- 西斯普拉丁化学疗法至关重要,但受到毒性和耐药性的限制.
- 纳米技术为优化西斯的输送提供了潜在的解决方案.
研究的目的:
- 对ORL癌症进行基于纳米技术的思普拉丁输送系统的审查.
- 分析纳米载体类型,机制,优势和局限性.
- 评估纳米技术增强的西斯的临床潜力.
主要方法:
- 对最近的研究和临床试验进行了全面的文献综述.
- 对各种纳米载体系统 (脂质,聚合物,无机,细胞外囊泡) 的分析.
- 对药物向,生物可用性,毒性和耐药性机制的评估.
主要成果:
- 纳米载体显示改善药物向性,生物可用性和降低毒性.
- 纳米技术有可能克服西斯普拉丁耐药性,并使组合治疗成为可能.
- 基于脂质,聚合物,无机纳米粒子和细胞外囊泡是有希望的纳米载体.
结论:
- 纳米技术为优化ORL癌症中西斯的输送提供了一个有前途的方法.
- 临床前数据显示出显著的潜力,但临床验证至关重要.
- 解决生物相容性,可扩展性和监管障碍对于采用至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K